No problem and your point about management shareholding is reassuring. You will note that Greg Collier has 18 million shares, as you know, he is also a director of POH where I don't think he holds any? Correct me if I am wrong. Did Greg offer any other information in your recent correspondence? Interesting about the patents. My understanding is Invion holds patenting rights for exclusivity on the drug and dosing while 3M have the patent rights on the inhaler. All 3 together make a strong patent that is a game changer in respiratory. 3M might be playing hardball?
IVX Price at posting:
0.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)